In a significant policy development, the Government of Gujarat has reversed its earlier decision to exempt stents from the purview of central pricing regulation under the Clinical Establishments Act. This comes after broad-based feedback and concern from industry stakeholders, patient advocacy groups, and healthcare experts.Simultaneously,